In type 2 diabetes mellitus, GLP‐1 receptor activation has been shown to reduce arterial blood pressure, due to a direct vasodilatory action combined with indirect actions on lowering body weight and inducing kidney natriuresis (Asmar et al., 2019). The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.